Overview

Opioid and Cannabinoid Interactions

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This study will examine the effects of doses of marijuana/placebo and doses of opioid/placebo, alone and in combination. The primary outcomes are related to pharmacodynamic measures (subjective ratings of drug liking and other abuse-related effects; physiological outcomes) to determine the interaction effects of these compounds.
Phase:
Phase 1
Details
Lead Sponsor:
Shanna Babalonis, PhD
Treatments:
Analgesics, Opioid